Detection of hepatitis C mutants with natural resistance to NS3/4A protease inhibitors in HIV/HCV-coinfected individuals treated with antiretroviral therapy

J Acquir Immune Defic Syndr. 2009 May 1;51(1):106-8. doi: 10.1097/QAI.0b013e3181a02fda.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Carrier Proteins / genetics
  • Drug Resistance, Viral / genetics
  • Female
  • Genes, Viral*
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • Hepacivirus / drug effects*
  • Hepacivirus / enzymology
  • Hepacivirus / genetics*
  • Hepatitis C / complications*
  • Hepatitis C / drug therapy
  • Hepatitis C / virology*
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Male
  • Middle Aged
  • Mutation*
  • Protease Inhibitors / pharmacology
  • Viral Nonstructural Proteins / genetics
  • Viral Proteins / genetics

Substances

  • Anti-HIV Agents
  • Carrier Proteins
  • Intracellular Signaling Peptides and Proteins
  • NS3 protein, hepatitis C virus
  • NS4A cofactor peptide, Hepatitis C virus
  • Protease Inhibitors
  • Viral Nonstructural Proteins
  • Viral Proteins